Rehabilitation for secondary lymphedema of lower limbs Lymphatic transportation measurement with ICG lymphography and the effect of rehabilitation

Rehabilitation for secondary lymphedema of lower limbs Lymphatic transportation measurement with ICG lymphography and the effect of rehabilitation - Rehabilitation and ICG lymphography for secondary lymphedema of lower limbs

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000004036

Enrollment

140

Registered

2010-09-01

Start date

2010-09-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Secondary lymphedema

Interventions

Method of ICG lymphography 1) supine position at rest(10 minutes). 2) Subcutaneous infusion of the dorsum of foot with 0.5ml of 1% Xylocain with a 29-gauge needle. 3) Bandage-like compression of a

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: 1. secondary lymphedema 2. lymphedema of lower limb 3. caused by uterus cancer, ovarian cancer and their therapies

Exclusion criteria

Exclusion criteria: 1.phlegmonitis 2.leakage of lymphatic fluid 3.deep venous thrombosis and sever aneurysm 4.poor general status(Performance Status 3 or more) 5.acute generalized inflammation and fever(38.0 centidegree or more) 6.severe heart failure 7.pulmonary embolism, acute respiratory failure, severe pulmonary hypertension 8.severe hepatic and renal failure 9.severe mental disorder, sever psychological diseases 10.other metabolic disorders (acute thyroiditis etc.)

Design outcomes

Primary

Measure	Time frame
1.function of lymphatic transportation 2. image of ICG lymphography	—

Secondary

Measure	Time frame
1.diameter of lower limb 2.thickness of skin tissue 3.sepecific symptoms related to lymphedema	—

Countries

Japan

Contacts

Public ContactTaro Okitsu

Keio University, School of Medicine Department of Rehabilitation Medicine

PXW13537@nifty.com03-5363-3833

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026